Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patients with PsA, Cutaneous Psoriasis May Undergo Hip Replacement

Richard Quinn  |  July 15, 2016

1shutterstock_HipBone_500x270Rheumatologists concerned about their patients with psoriatic arthritis and cutaneous psoriasis who are considering a hip replacement can rest assured: neither disease is a risk factor for worse outcomes after total hip arthroplasty, according to the lead author of a study published in Arthritis & Rheumatology.

The results, published in an article titled “Short-Term Total Hip Arthroplasty Outcomes in Patients with Psoriatic Arthritis or Psoriatic Skin Disease Compared to Patients with Osteoarthritis,” actually surprised its lead author, Lisa A. Mandl, MD, MPH, a rheumatologist at the Hospital for Special Surgery and assistant research professor at Weill Cornell, both in New York City.1

Lisa A. Mandl, MD, MPH

Lisa A. Mandl, MD, MPH

“When we saw the final results—really no differences between patients with osteoarthritis, skin psoriasis or inflammatory psoriatic arthritis in their results after they have the hip replaced—I was happy to be proven wrong,” says Dr. Mandl. “We were concerned that the inflammation associated with psoriatic arthritis, and [patients’] tendency to build bone, might make [those patients] more prone to worse outcomes. However, this was not the case.”

According to the article, investigators examined two years of self-reported data for 153 validated cases of psoriatic arthritis and cutaneous psoriasis, all cases matched with patients with osteoarthritis as controls. No significant differences were found in pre- or postoperative Western Ontario and McMaster Universities OA Index scores for pain or function between the three groups. In regression analyses, neither psoriatic arthritis nor cutaneous psoriasis was a risk factor for worse outcomes after total hip arthroplasty. Also, patient satisfaction was high among all three groups (P=0.54).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Psoriatic arthritis affects more than 7 million Americans and can be difficult to diagnose, Dr. Mandl says, because it often affects relatively young and otherwise healthy patients. Some patients initially relate arthritis pain to sports injuries or overuse and, “therefore, are late coming to medical attention.”

“It’s very encouraging to be able to tell our patients who have psoriatic arthritis and end-stage damage to their hips that if they choose to have the hip replaced they should do very well,” Dr. Mandl says. “[For clinicians], there is no reason to discourage patients with psoriatic arthritis from having their hip replaced if they need it, as they will do equally well as patients with osteoarthritis who we know have excellent outcomes.”

Richard Quinn is a freelance writer in New Jersey.

Reference

  1. Mandl LA, Zhu R, Huang WT, et al. Short-term total hip arthroplasty outcomes in patients with psoriatic arthritis or psoriatic skin disease compared to patients with osteoarthritis. Arthritis Rheumatol. 2016 Feb;68(2):410–417. doi: 10.1002/art.39431.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic ArthritisResearch Rheum Tagged with:Arthritis & Rheumatologyhiphip arthroplastyhip replacementPsoriasisPsoriatic Arthritis

Related Articles

    Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement

    December 1, 2014

    Resurfacing procedure preserves bone, lasts longer, allows patients higher level of functionality

    Tips from a Joint Surgeon on What the Rheumatologist Needs to Know

    June 18, 2022

    Hip and knee replacements—despite advancement in treatments for rheumatic diseases, some patients will still need to undergo these surgeries. Here are insights into the considerations, costs and complications of total joint arthroplasty.

    Right: The same view as 2A, with the common peroneal nerve outlined in yellow with a cross-sectional area of 21 mm2.

    Case Report: Ultrasound Reveals Cause of Post-Arthroplasty Knee Pain

    April 15, 2020

    A 65-year-old woman was referred by an orthopedist to a rheumatologist for left knee pain. Previously, in 2014, she underwent left total knee arthroplasty (TKA) for severe osteoarthritis in a different institution. Following the procedure, she experienced severe chronic anterolateral knee pain at rest, exacerbated by walking. Because she was rendered wheelchair bound and required…

    State-of-the-Art Approaches to Rheumatic Disease Diagnosis, Management & Treatment

    March 19, 2019

    CHICAGO—Held during the 2018 ACR/ARHP Annual Meeting, the ACR Review Course covered a wide range of topics for rheumatologists—from advances in pain and rheumatic disease management to the intersection of rheumatology and neurology. Session speakers shared insights, as well as state-of-the-art approaches to diagnosis, management and treatment. Inflammatory Myopathies Julie J. Paik, MD, MHS, assistant…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences